|
Dr. Swenson previously served as Executive Director of Preclinical Development and R&D Site Manager at Elan Pharmaceuticals (previously The Liposome Company). In this capacity, Dr. Swenson advanced non-clinical pharmacology and toxicology programs that ultimately resulted in four successful IND applications in the U.S. and two successful marketing applications for products currently sold in the U.S., Europe and Canada. Dr. Swenson has authored over 50 scientific publications. She earned her Ph.D. from Cornell University Graduate School of Medical Sciences in New York City, and conducted post-doctoral research at Rockefeller University in New York City and at the University of California in San Francisco. | 